联环药业：9月12日召开董事会会议

Group 1 - The core point of the article is that Lianhuan Pharmaceutical (SH 600513) held a temporary board meeting on September 12, 2025, to discuss the proposal for the third extraordinary shareholders' meeting of 2025 [1] - For the year 2024, Lianhuan Pharmaceutical's revenue composition is as follows: pharmaceutical distribution accounts for 59.36%, pharmaceutical manufacturing accounts for 40.38%, and other businesses account for 0.26% [1] - As of the report date, Lianhuan Pharmaceutical has a market capitalization of 6.5 billion yuan [1]